This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/business/529602-gates-soros-covid-testing-company/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| George Soros & Bill Gates lead buyout of UK Covid testing company | George Soros & Bill Gates lead buyout of UK Covid testing company |
| (about 1 month later) | |
| A group of investors led by the Soros Economic Development Fund (SEDF) and the Bill & | A group of investors led by the Soros Economic Development Fund (SEDF) and the Bill & |
| Melinda Gates Foundation have financed the buyout of UK diagnostic technologies firm Mologic, which has developed a 10-minute coronavirus test. | Melinda Gates Foundation have financed the buyout of UK diagnostic technologies firm Mologic, which has developed a 10-minute coronavirus test. |
| To make the acquisition, the group has launched Global Access Health (GAH), a social enterprise aiming to expand access to affordable medical technology. The members of the GAH are reportedly set on investing over $41 billion in the acquisition deal. The transaction will include the buyout of all Mologic’s existing shares, including those held by two private investment managers, Foresight Group LLP and Calculus Capital. | To make the acquisition, the group has launched Global Access Health (GAH), a social enterprise aiming to expand access to affordable medical technology. The members of the GAH are reportedly set on investing over $41 billion in the acquisition deal. The transaction will include the buyout of all Mologic’s existing shares, including those held by two private investment managers, Foresight Group LLP and Calculus Capital. |
| “The COVID-19 pandemic has painfully demonstrated the fundamental inequities in global public health, and in particular the crucial importance of access to […] life-saving diagnostic tools. In this unique transaction, philanthropic funds and investors are working together […] to address at least one part of that failure by enabling a cutting-edge commercial business to focus all its resources on solving one of the world’s most pressing public health issues,” Sean Hinton, SEDF’s chief executive officer, has said, commenting on the deal. | “The COVID-19 pandemic has painfully demonstrated the fundamental inequities in global public health, and in particular the crucial importance of access to […] life-saving diagnostic tools. In this unique transaction, philanthropic funds and investors are working together […] to address at least one part of that failure by enabling a cutting-edge commercial business to focus all its resources on solving one of the world’s most pressing public health issues,” Sean Hinton, SEDF’s chief executive officer, has said, commenting on the deal. |
| Mologic was founded in 2003 by Mark Davis and his father Professor Paul Davis, one of the creators of the world's first home pregnancy test, ClearBlue. Mologic develops tests for a variety of diseases at affordable prices and recently received a CE mark (Conformité Européenne) for its coronavirus disease Covid-19 tests, which the company plans to sell at just $1 each. | Mologic was founded in 2003 by Mark Davis and his father Professor Paul Davis, one of the creators of the world's first home pregnancy test, ClearBlue. Mologic develops tests for a variety of diseases at affordable prices and recently received a CE mark (Conformité Européenne) for its coronavirus disease Covid-19 tests, which the company plans to sell at just $1 each. |
| However, the Covid-19 test has yet to be approved for use in both the UK and the US. Mologic recently received £1 million ($1.4 million) from the UK authorities for its Covid-19 tests development, but later accused the government of “stonewalling” the usage of the tests within the country. | However, the Covid-19 test has yet to be approved for use in both the UK and the US. Mologic recently received £1 million ($1.4 million) from the UK authorities for its Covid-19 tests development, but later accused the government of “stonewalling” the usage of the tests within the country. |
| Mologic’s CEO Mark Davis welcomed the acquisition deal, stating that it means a transformation of his company into a social enterprise which he dubbed “a deliberate, logical and natural step focused on delivering affordable diagnostics and biotechnology to places that have been left underserved by the relentless pursuit of profiteering.” | Mologic’s CEO Mark Davis welcomed the acquisition deal, stating that it means a transformation of his company into a social enterprise which he dubbed “a deliberate, logical and natural step focused on delivering affordable diagnostics and biotechnology to places that have been left underserved by the relentless pursuit of profiteering.” |
| For more stories on economy & finance visit RT's business section | For more stories on economy & finance visit RT's business section |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |